BIOMAT Database Logo BIOMAT Database Logo

Discovery of 5,6-diaryl-1,2,4-triazines hybrids as potential apoptosis inducers. 2017

Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, China; Key Laboratory of Technology of Drug Preparation, Zhengzhou University, Ministry of Education, China; Key Laboratory of Henan Province for Drug Quality and Evaluation, China.

A series of 5,6-diaryl-1,2,4-triazines hybrids bearing a 1,2,3-triazole linker were synthesized by molecular hybridization strategy and evaluated for antiproliferative activity against three selected cancer cell lines (MGC-803, EC-109 and PC-3). The first structure-activity relationship (SAR) for these 5,6-diaryl-1,2,4-triazines is explored in this report with evaluation of 15 variants of the structural class. Among these chemical derivatives, 3-(((1-(4-fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl)thio)-5,6-diphenyl-1,2,4-triazine (11E) showed the more potent inhibitory effect against three cell lines than 5-Fu. Cellular mechanism studies in MGC-803 cells elucidated 11E inhibited colony formation and arrested cell cycle at G2/M phase. Furthermore, compound 11E caused morphological changes, decreased mitochondrial membrane potential, and induced apoptosis through the apoptosis-related proteins in MGC-803 cells. It was the first time, to our knowledge, that 5,6-diaryl-1,2,4-triazines bearing a 1,2,3-triazole linker were used as potential apoptosis inducers.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Design, green synthesis and pharmacological evaluation of novel 5,6-diaryl-1,2,4-triazines bearing 3-morpholinoethylamine moiety as potential antithrombotic agents (.).
October 2016, Journal of enzyme inhibition and medicinal chemistry,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents.
November 1985, Journal of medicinal chemistry,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
May 2017, Archiv der Pharmazie,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Efficient routes to pyrazolo[3,4-e][1,2,4]triazines and a new ring system: [1,2,4]triazino[5,6-d][1,2,3]triazines.
May 2010, Molecules (Basel, Switzerland),
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Discovery of pyridine- sulfonamide hybrids as a new scaffold for the development of potential VEGFR-2 inhibitors and apoptosis inducers.
June 2021, Bioorganic chemistry,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Synthesis and anticonvulsant activity of some potent 5,6-bis aryl 1,2,4-triazines.
July 2007, Journal of Zhejiang University. Science. B,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Discovery of novel 1,2,4-triazolo-1,2,4-triazines with thiomethylpyridine hinge binders as potent c-Met kinase inhibitors.
May 2019, Future medicinal chemistry,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.
August 2005, Journal of medicinal chemistry,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
One pot synthesis and SAR of some novel 3-substituted 5,6-diphenyl-1,2,4-triazines as antifungal agents.
January 2010, Bioorganic & medicinal chemistry letters,
Dong-Jun Fu, and Jian Song, and Yu-Hui Hou, and Ruo-Han Zhao, and Jia-Huan Li, and Ruo-Wang Mao, and Jia-Jia Yang, and Ping Li, and Xiao-Lin Zi, and Zhong-Hua Li, and Qing-Qing Zhang, and Fei-Yan Wang, and Sai-Yang Zhang, and Yan-Bing Zhang, and Hong-Min Liu
[Studies on as-triazine derivatives. XVIII. Synthesis of 5,6-diaryl-1,2,4-triazine derivatives as blood platelet aggregation inhibitors].
October 1992, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!